Furthermore, sorafenib‐induced tumor growth inhibition and ferroptosis were further enhanced after MK2 knockout, which was completely abolished by ferrostatin‐1 treatment (Figure 5J–L; Figure S8H, I, Supporting Information). The gene discussed is MAPKAPK2; the disease is neoplasm.